Evidence map›Paper›PMID 27798618›Full record

ArticleNature immunology2016

Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.

Rui Martins, Julia Maier, Anna-Dorothea Gorki, Kilian V M Huber, Omar Sharif, Philipp Starkl, Simona Saluzzo, Federica Quattrone, Riem Gawish, Karin Lakovits and 18 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 141 citations in OpenAlex.

  1. Haemolytic injury and cardiovascular disease.Nature reviews. Cardiology · 2026
    Review
  2. Ferroptosis is a Physiologic Vulnerability of Iron-Recycling Macrophages.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. DOCK8 in immune cells: roles and mechanisms.Frontiers in immunology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 3 countries.

Rui MartinsCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Julia MaierCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0001-9814-523X
Anna-Dorothea GorkiCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Kilian V M HuberCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0002-1103-5300
Omar SharifCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Philipp StarklCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Simona SaluzzoCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Federica QuattroneCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Riem GawishCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Karin LakovitsDepartment of Medicine I, Laboratory of Infection Biology, Medical University of Vienna, Vienna, Austria.
Michael C AichingerMax F. Perutz Laboratories, University of Vienna, Vienna, Austria.
Branka Radic-SarikasCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Charles-Hugues LardeauCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Anastasiya HladikCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Ana KorosecCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Markus BrownDepartment of Pathology, Medical University of Vienna, Vienna, Austria.
Kari VaahtomeriIST Austria (Institute of Science and Technology Austria), Klosterneuburg, Austria.
Michelle DugganIST Austria (Institute of Science and Technology Austria), Klosterneuburg, Austria.
Dontscho KerjaschkiDepartment of Pathology, Medical University of Vienna, Vienna, Austria.
Harald EsterbauerClinical Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria.
Jacques ColingeCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Stephanie C EisenbarthDepartment of Laboratory Medicine and Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Thomas DeckerMax F. Perutz Laboratories, University of Vienna, Vienna, Austria.
Keiryn L BennettCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0001-9356-7708
Stefan KubicekCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0003-0855-8343
Michael SixtIST Austria (Institute of Science and Technology Austria), Klosterneuburg, Austria.
Giulio Superti-FurgaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Sylvia KnappCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0001-9016-5244
Austrian Academy of Sciences · ATMedical University of Vienna · ATInstitute of Science and Technology Austria · ATUniversity of Vienna · ATYale University · US

Funding

Austrian Science Fund FWF I 1620Austrian Science Fund FWF I 1674
6 · The paper itself

Abstract

Hemolysis drives susceptibility to bacterial infections and predicts poor outcome from sepsis. These detrimental effects are commonly considered to be a consequence of heme-iron serving as a nutrient for bacteria. We employed a Gram-negative sepsis model and found that elevated heme levels impaired the control of bacterial proliferation independently of heme-iron acquisition by pathogens. Heme strongly inhibited phagocytosis and the migration of human and mouse phagocytes by disrupting actin cytoskeletal dynamics via activation of the GTP-binding Rho family protein Cdc42 by the guanine nucleotide exchange factor DOCK8. A chemical screening approach revealed that quinine effectively prevented heme effects on the cytoskeleton, restored phagocytosis and improved survival in sepsis. These mechanistic insights provide potential therapeutic targets for patients with sepsis or hemolytic disorders.

Indexed as

PhagocytosisAnimalsAnti-Bacterial Agentscdc42 GTP-Binding ProteinCytoskeletonFemaleGram-Negative Bacterial InfectionsGuanine Nucleotide Exchange FactorsHemeHeme Oxygenase-1HemolysisHumansImmune EvasionMacrophagesMembrane ProteinsMiceAnti-Bacterial Agentscdc42 GTP-Binding ProteinDock8 protein, mouseGuanine Nucleotide Exchange FactorsHemeHeme Oxygenase-1Hmox1 protein, mouseMembrane ProteinsQuinine

Identifiers

PMID27798618
OpenAlexW2541386409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.